Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a non-Hodgkin T-cell lymphoma, occurring adjacent to a breast implant implanted for either reconstruction or cosmetic purposes, characterized by the proliferation of large pleomorphic tumor cells uniformly expressing CD30 and negative for anaplastic lymphoma kinase (ALK) protein (1). Here, ALK is linked to anaplastic large cell lymphoma.